) C-

T polymor- phism in the TGFB

gene promoter: impact on Crohn’s disease sus- ceptibility and clinical course?. Immunogenetics

,

–

Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D (

) Targeted disruption of the mouse transforming growth factor-beta

gene results in multifocal inflammatory disease. Nature

,

–

Smith WB, Noack L, Khew-Goodall Y, Isenmann S, Vadas MA, Gamble JR (

) Transforming growth factor-beta

inhibits the production of IL-

and the transmigration of neutrophils through activated endothelium. J. Immunol.

,

–

Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C (

) Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med.

,

–

Weiss JM, Cuff CA, Berman JW (

) TGF-beta downmodulates cytokine-induced monocyte chemoattractant protein (MCP)-

expres- sion in human endothelial cells. A putative role for TGF-beta in the modulation of TNF receptor expression. Endothelium

,

–

Wyss-Coray T, Lin C, Sanan DA, Mucke L, Masliah E (

) Chronic overproduction of transforming growth factor-beta

by astrocytes promotes Alzheimer’s disease-like microvascular degeneration in transgenic mice. Am. J. Pathol.

,

–

Yamada Y (

) Association of a Leu (

)→Pro polymorphism of the transforming growth factor-beta

with genetic susceptibility to oste- oporosis and spinal osteoarthritis. Mech. Ageing Dev.

,

–

Young DG, Skibinski G, Mason JI, James K (

) The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-

, IL-

soluble receptor (IL-

) and transforming growth factor beta

(TGF-beta

) levels in normal healthy blood donors. Clin. Exp. Immunol.

,

–